Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies

Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome the infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Citterio, Chiara, Lazzaro, Antonio, Bosi, Costanza, De Ponzio, Maurice, Cavanna, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190583/
https://www.ncbi.nlm.nih.gov/pubmed/34136224
http://dx.doi.org/10.1002/ccr3.4013
Descripción
Sumario:Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome the infection, also in hematological patients.

Ejemplares similares